Evidence map›Paper›PMID 42277033›Full record

ArticleNature communications2026

HnRNP A1 and A2B1 enforce Ezh2 mRNA splicing to promote germinal center B cell responses.

Zhijian Zhu, Rui Zhang, Haoran Kang, Meiyuan Chen, Hengjun Huang, Jing Wang, Ling Guo, Yuxing Li, Wenjing Chen, Limin Meng and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zhijian Zhu *Department of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Rui Zhang *Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Haoran KangDepartment of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Meiyuan ChenDepartment of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Hengjun HuangJiangxi Province Key Laboratory of Traditional Chinese Medicine Pharmacology, Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang, China.ORCID http://orcid.org/0000-0001-9842-9312
Jing WangDepartment of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Ling GuoDepartment of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Yuxing LiSchool of Biological and Pharmaceutical Engineering, Lanzhou Jiaotong University, Lanzhou, China.
Wenjing ChenDepartment of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Limin MengDepartment of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Ruisi WangDepartment of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Ling LiDepartment of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Kong-Peng LamSingapore Immunology Network, Agency for Science, Technology and Research, Immunos Building, 8A Biomedical Grove, Singapore, Singapore.ORCID http://orcid.org/0000-0002-1316-4333
Shengli XuSingapore Immunology Network, Agency for Science, Technology and Research, Immunos Building, 8A Biomedical Grove, Singapore, Singapore. xu_shengli@a-star.edu.sg.ORCID http://orcid.org/0000-0002-2541-3608
Xijun OuDepartment of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China. ouxj@sustech.edu.cn.ORCID http://orcid.org/0000-0002-4525-5205

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterogeneous nuclear ribonucleoproteins (hnRNP) are key regulators of gene expression, yet the physiological functions of the highly homologous hnRNP A1 and A2B1 in B cells remain unclear. Here, we conditionally delete Hnrnpa1 and Hnrnpa2b1 in mouse B cells and find that loss of hnRNP A1 and A2B1 compromises the germinal center (GC) reaction during T cell-dependent immune responses. Loss of hnRNP A1 and A2B1 impairs GC B cell proliferation and high-affinity antibody production. Mechanistically, hnRNP A1/A2B1 bind UAG-rich motifs in Ezh2 pre-mRNA to promote Ezh2 exon 14 inclusion, thereby preserving EZH2 catalytic activity; in their absence, Ezh2 exon 14-skipping produces a catalytically inactive EZH2 isoform (Ezh2Δ14) with diminished repression of the cell cycle inhibitor Cdkn1a. The resulting CDKN1A accumulation restricts B cell proliferation, while Cdkn1a deletion partially rescues the GC defects in B cells deficient for hnRNP A1 and A2B1. Our findings thus uncover an hnRNP A1/A2B1-EZH2-CDKN1A axis that integrates RNA splicing with epigenetic regulation of B cell immunity.

Indexed as

B-LymphocytesEnhancer of Zeste Homolog 2 ProteinGerminal CenterHeterogeneous Nuclear Ribonucleoprotein A1Heterogeneous-Nuclear Ribonucleoprotein Group A-BRNA SplicingAnimalsCell ProliferationCyclin-Dependent Kinase Inhibitor p21ExonsMiceMice, Inbred C57BLMice, KnockoutRNA, MessengerCyclin-Dependent Kinase Inhibitor p21Enhancer of Zeste Homolog 2 ProteinEzh2 protein, mouseHeterogeneous Nuclear Ribonucleoprotein A1Heterogeneous-Nuclear Ribonucleoprotein Group A-BHnrnpa1 protein, mousehnRNP A2RNA, Messenger

Identifiers

PMID42277033
PMCPMC13408116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.